Coloplast A/S (COLO-B) - Total Assets

Latest as of December 2025: Dkr48.80 Billion DKK ≈ $7.63 Billion USD

Based on the latest financial reports, Coloplast A/S (COLO-B) holds total assets worth Dkr48.80 Billion DKK (≈ $7.63 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Coloplast A/S - Total Assets Trend (2002–2025)

This chart illustrates how Coloplast A/S's total assets have evolved over time, based on quarterly financial data. Also see how much is Coloplast A/S worth for the company's overall valuation and market capitalisation.

Coloplast A/S - Asset Composition Analysis

Current Asset Composition (September 2025)

Coloplast A/S's total assets of Dkr48.80 Billion consist of 21.6% current assets and 78.4% non-current assets. Review Coloplast A/S debt and liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (DKK)	% of Total Assets
Cash & Equivalents	Dkr0.00	2.0%
Accounts Receivable	Dkr5.18 Billion	10.7%
Inventory	Dkr3.92 Billion	8.1%
Property, Plant & Equipment	Dkr0.00	0.0%
Intangible Assets	Dkr10.48 Billion	21.7%
Goodwill	Dkr19.33 Billion	40.0%

Asset Composition Trend (2002–2025)

This chart illustrates how Coloplast A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See COLO-B stock price and chart for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Coloplast A/S's current assets represent 21.6% of total assets in 2025, a decrease from 58.1% in 2002.
Cash Position: Cash and equivalents constituted 2.0% of total assets in 2025, down from 7.1% in 2002.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, an increase from 0.0% in 2002.
Asset Diversification: The largest asset category is goodwill at 40.0% of total assets.

Coloplast A/S Competitors by Total Assets

Key competitors of Coloplast A/S based on total assets are shown below.

Company	Country	Total Assets
Gan & Lee Pharmaceuticals Co Ltd SHG:603087	China	CN¥12.68 Billion
Andon Health Co Ltd SHE:002432	China	CN¥29.91 Billion
Shenyang Xingqi Pharmaceutical Co Ltd SHE:300573	China	CN¥2.42 Billion
Pegavision TW:6491	Taiwan	NT$16.17 Billion
Nanosonics Ltd AU:NAN	Australia	AU$279.25 Million
Visco Vision Inc. TW:6782	Taiwan	NT$5.82 Billion
QITIAN Technology Group Co Ltd SHE:300061	China	CN¥1.17 Billion
Embecta Corp NASDAQ:EMBC	USA	$1.27 Billion

Coloplast A/S - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.30	0.81	0.98
Quick Ratio	0.81	0.52	0.65
Cash Ratio	0.00	0.00	0.00
Working Capital	Dkr2.37 Billion	Dkr-2.40 Billion	Dkr-115.00 Million

Coloplast A/S - Advanced Valuation Insights

This section examines the relationship between Coloplast A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	7.76
Latest Market Cap to Assets Ratio	0.28
Asset Growth Rate (YoY)	0.6%
Total Assets	Dkr48.37 Billion
Market Capitalization	$13.62 Billion USD

Valuation Analysis

Below Book Valuation: The market values Coloplast A/S's assets below their book value (0.28x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Coloplast A/S's assets grew by 0.6% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Coloplast A/S (2002–2025)

The table below shows the annual total assets of Coloplast A/S from 2002 to 2025.

Year	Total Assets	Change
2025-09-30	Dkr48.37 Billion ≈ $7.57 Billion	+0.61%
2024-09-30	Dkr48.07 Billion ≈ $7.52 Billion	-0.18%
2023-09-30	Dkr48.16 Billion ≈ $7.53 Billion	+37.77%
2022-09-30	Dkr34.96 Billion ≈ $5.47 Billion	+120.67%
2021-09-30	Dkr15.84 Billion ≈ $2.48 Billion	+17.35%
2020-09-30	Dkr13.50 Billion ≈ $2.11 Billion	+6.02%
2019-09-30	Dkr12.73 Billion ≈ $1.99 Billion	+8.18%
2018-09-30	Dkr11.77 Billion ≈ $1.84 Billion	-2.33%
2017-09-30	Dkr12.05 Billion ≈ $1.89 Billion	+9.48%
2016-09-30	Dkr11.01 Billion ≈ $1.72 Billion	+1.76%
2015-09-30	Dkr10.82 Billion ≈ $1.69 Billion	+4.22%
2014-09-30	Dkr10.38 Billion ≈ $1.62 Billion	+10.84%
2013-09-30	Dkr9.36 Billion ≈ $1.47 Billion	-7.98%
2012-09-30	Dkr10.18 Billion ≈ $1.59 Billion	+10.39%
2011-09-30	Dkr9.22 Billion ≈ $1.44 Billion	+18.62%
2010-09-30	Dkr7.77 Billion ≈ $1.22 Billion	-2.41%
2009-09-30	Dkr7.96 Billion ≈ $1.25 Billion	-0.23%
2008-09-30	Dkr7.98 Billion ≈ $1.25 Billion	+2.98%
2007-09-30	Dkr7.75 Billion ≈ $1.21 Billion	-2.91%
2006-09-30	Dkr7.98 Billion ≈ $1.25 Billion	+34.95%
2005-09-30	Dkr5.92 Billion ≈ $925.44 Million	+4.86%
2004-09-30	Dkr5.64 Billion ≈ $882.53 Million	+5.24%
2003-09-30	Dkr5.36 Billion ≈ $838.61 Million	+19.40%
2002-09-30	Dkr4.49 Billion ≈ $702.34 Million	--

About Coloplast A/S

CO:COLO-B Denmark Medical Instruments & Supplies

Market Cap

$13.62 Billion

Dkr87.03 Billion DKK

Market Cap Rank

#1759 Global

#11 in Denmark

Share Price

Dkr419.70

Change (1 day)

+0.12%

52-Week Range

Dkr372.30 - Dkr614.80

All Time High

Dkr1106.54